These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 20738958)
1. [Spanish Neurology Society consensus document on the use of drugs in multiple sclerosis: escalating therapy]. García Merino A; Fernández O; Montalbán X; de Andrés C; Arbizu T Neurologia; 2010; 25(6):378-90. PubMed ID: 20738958 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of multiple sclerosis--now and in future. The Danish Multiple Sclerosis Society and the Danish Multiple Sclerosis Group]. Sellebjerg FT; Sørensen PS; Ugeskr Laeger; 2007 Mar; 169(12):1121. PubMed ID: 17394832 [No Abstract] [Full Text] [Related]
3. [Combined therapy in multiple sclerosis]. García-Merino JA; Blasco-Quítez MR; Ortiz-Benítez P; Puerta C Rev Neurol; 2003 Mar 16-31; 36(6):545-9. PubMed ID: 12652419 [TBL] [Abstract][Full Text] [Related]
9. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities. Stuart WH Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719 [TBL] [Abstract][Full Text] [Related]
10. The curtain is drawn for both natalizumab and fingolimod (FTY720): a new era of multiple sclerosis therapy has arrived. Weissert R Expert Rev Neurother; 2006 Nov; 6(11):1587-90. PubMed ID: 17144774 [No Abstract] [Full Text] [Related]
11. [Intensive immunosuppressive treatment of chronic progressive multiple sclerosis]. Hommes OR Ned Tijdschr Geneeskd; 1978 Oct; 122(41):1545-51. PubMed ID: 358004 [No Abstract] [Full Text] [Related]
12. Multiple sclerosis poses tough drug development challenges. Senior K Drug Discov Today; 2005 Dec; 10(23-24):1583-4. PubMed ID: 16376813 [No Abstract] [Full Text] [Related]
13. [Pharmacological treatment of multiple sclerosis]. Myhr KM Tidsskr Nor Laegeforen; 2010 Mar; 130(5):490-2. PubMed ID: 20224616 [TBL] [Abstract][Full Text] [Related]
14. Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016. García Merino A; Ramón Ara Callizo J; Fernández Fernández O; Landete Pascual L; Moral Torres E; Rodríguez-Antigüedad Zarrantz A Neurologia; 2017 Mar; 32(2):113-119. PubMed ID: 27157522 [TBL] [Abstract][Full Text] [Related]
15. Daclizumab treatment for multiple sclerosis. Kim SE Pharmacotherapy; 2009 Feb; 29(2):227-35. PubMed ID: 19170591 [TBL] [Abstract][Full Text] [Related]
17. Concepts of induction and escalation therapy in multiple sclerosis. Rieckmann P J Neurol Sci; 2009 Feb; 277 Suppl 1():S42-5. PubMed ID: 19200866 [TBL] [Abstract][Full Text] [Related]
18. Translating new insights into treatment optimisation in multiple sclerosis. Fazekas F; Kieseier BC J Neurol Sci; 2009 Feb; 277 Suppl 1():S1-2. PubMed ID: 19200857 [No Abstract] [Full Text] [Related]
19. Modern multiple sclerosis treatment - what is approved, what is on the horizon. Pilz G; Wipfler P; Ladurner G; Kraus J Drug Discov Today; 2008 Dec; 13(23-24):1013-25. PubMed ID: 18775508 [TBL] [Abstract][Full Text] [Related]
20. The history of multiple sclerosis: the changing frame of the disease over the centuries. Murray TJ J Neurol Sci; 2009 Feb; 277 Suppl 1():S3-8. PubMed ID: 19200863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]